- 专利标题： PHARMACEUTICAL COMPOSITION CONTAINING ANTI-TSLP ANTIBODY
-
申请号： EP22762538.1申请日： 2022-03-02
-
公开(公告)号： EP4302778A1公开(公告)日： 2024-01-10
- 发明人: KONG, Lingjie , CHENG, Yanju , GUO, Xiaolu
- 申请人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- 申请人地址： CN Lianyungang, Jiangsu 222062 No. 369 Yuzhou South Rd.,
- 代理机构： Grünecker Patent- und Rechtsanwälte PartG mbB
- 优先权： CN202110235660 20210303
- 国际公布： WO2022184074 20220909
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/24 ; C12N15/13 ; A61P37/02
摘要：
Provided are a pharmaceutical composition containing an anti-TSLP antibody, and a use thereof. In particular, provided are a pharmaceutical composition, containing (a) an anti-TSLP antibody, (b) a buffer, (c) a surfactant, and one or more (d) stabilizers, and a use of the pharmaceutical composition in preparation of a medicament for treating and preventing TSLP-related diseases.
信息查询
